Last reviewed · How we verify
Codeine paracetamol
Codeine acts as a weak opioid agonist while paracetamol inhibits prostaglandin synthesis, together providing analgesic and antipyretic effects.
Codeine acts as a weak opioid agonist while paracetamol inhibits prostaglandin synthesis, together providing analgesic and antipyretic effects. Used for Moderate acute pain, Mild to moderate chronic pain.
At a glance
| Generic name | Codeine paracetamol |
|---|---|
| Also known as | Co-codamol tablets |
| Sponsor | Napp Pharmaceuticals Limited |
| Drug class | Opioid analgesic combination |
| Target | Opioid receptors (μ, δ, κ); cyclooxygenase (COX-1, COX-2) |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | FDA-approved |
Mechanism of action
Codeine binds to opioid receptors in the central nervous system to reduce pain perception, while paracetamol (acetaminophen) inhibits cyclooxygenase enzymes to decrease prostaglandin production, lowering pain and fever. The combination provides synergistic analgesia for moderate pain relief with lower opioid doses than codeine alone.
Approved indications
- Moderate acute pain
- Mild to moderate chronic pain
Common side effects
- Constipation
- Nausea
- Dizziness
- Drowsiness
- Vomiting
- Headache
- Hepatotoxicity (paracetamol overdose)
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304) (PHASE2)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy (PHASE2, PHASE3)
- Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial (PHASE4)
- Opioid-Free Pain Protocol After Shoulder Arthroplasty (PHASE4)
- Opioid-Sparing Joint Replacement (PHASE3)
- Reduced Opioid Prescription After Laparoscopic Hysterectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |